Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NeoGenomics Laboratories
AddedFeb 19, 2024
UpdatedJun 18, 2026
NeoGenomics Laboratories

NeoGenomics Laboratories

Acquired

NeoGenomics, a Florida-based clinical lab, specializes in advanced cancer genetics diagnostic testing.

HQ
Aliso Viejo, CA, US
Founded
2002
Overview
Compare
Fundraising
Employees

NeoGenomics Laboratories, based in Fort Myers, Florida, specializes in advanced cancer genetics diagnostic testing. The company offers a range of high-complexity CLIA-certified services, including cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. NeoGenomics serves both clinical and pharmaceutical markets, aiming to provide precise and comprehensive diagnostic information.

NeoGenomics has made significant strides in the field of cancer diagnostics, contributing to improved patient outcomes through innovative testing solutions. The company collaborates with leading healthcare providers and pharmaceutical firms to enhance cancer treatment and research. Its impact is evident in the widespread adoption of its diagnostic services, which support personalized medicine and targeted therapies.

NeoGenomics Laboratories - Similar Companies

Foundation Medicine logo

Foundation Medicine

Neodiagnostix logo

Neodiagnostix

neodiagnostix.com

LabGenomics Co. logo

LabGenomics Co.

Myriad Genetics logo

Myriad Genetics

myriad.com

Pathway Genomics logo

Pathway Genomics

Veracyte logo

Veracyte

veracyte.com

CancerGuide Diagnostics logo

CancerGuide Diagnostics

Fulgent Genetics logo

Fulgent Genetics

Protean Biodiagnostics logo

Protean Biodiagnostics

proteanbiodx.com

Personal Genome Diagnostics logo

Personal Genome Diagnostics

personalgenome.com

Invitae logo

Invitae

invitae.com

GeneDx Holdings logo

GeneDx Holdings

genedx.com

Liquid Genomics logo

Liquid Genomics

Natera logo

Natera

natera.com

Fulgent Diagnostics logo

Fulgent Diagnostics

NeoGenomics Laboratories - Quick Facts

Who are NeoGenomics Laboratories' competitors?

Companies similar to NeoGenomics Laboratories include Foundation Medicine, Neodiagnostix, LabGenomics Co. and Myriad Genetics.

When was NeoGenomics Laboratories founded?

NeoGenomics Laboratories was founded in 2002.

Where is NeoGenomics Laboratories' headquarters located?

NeoGenomics Laboratories' headquarters is located in Aliso Viejo, CA, US.

When was NeoGenomics Laboratories' last funding round?

NeoGenomics Laboratories' most recent funding round was for $200M (USD) in May 2021.

How much has NeoGenomics Laboratories raised to-date?

As of May 5, 2021, NeoGenomics Laboratories has raised a total of $350.5M (USD).

NeoGenomics Laboratories - Classification

Ownership
  • Public
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Cancer Diagnostics
Tags
  • Biotech
  • Data
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8734Testing Laboratories
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
ISIC
  • 7120Technical testing and analysis
  • 7500Veterinary activities
Show 21 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 541380Testing Laboratories and Services
  • 541713Research and Development in Nanotechnology
  • 541940Veterinary Services
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 541300Architectural, Engineering, and Related Services
  • 541900Other Professional, Scientific, and Technical Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 2800Chemicals And Allied Products
  • 6000Depository Institutions
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering